t

AI Summary

Invesco NASDAQ Biotech UCITS ETF reported its Net Asset Value (NAV) per share and the total number of shares in issue. For the dealing date of April 28, 2026, the NAV per share was USD 60.6491, and the total number of shares in issue was 6,501,123.00.

RNS Metadata

Date	29 Apr 2026
Time	10:09:16
Category	Corporate updates
ID	4036C

/Equities/XLON/SBIX/RNS

Net Asset Value(s)

RNS Number : 4036C

IVZ Nasdaq Biotech UCITS £

29 April 2026


FUND:	Invesco NASDAQ Biotech UCITS ETF
DEALING DATE:	28-Apr-26
NAV PER SHARE:	USD:60.6491
NUMBER OF SHARES IN ISSUE:	6,501,123.00
CODE:	SBIX

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NAVGZGZDLLZGVZG

AI Summary

RNS Metadata

Date	29 Apr 2026
Time	10:09:16
Category	Corporate updates
ID	4036C

t

Company Information

AI Summary

RNS Metadata

Net Asset Value(s)

Company Information

AI Summary

RNS Metadata